Skip to main content

Breast Cancer Learning Library

Videos
05/29/2026
Katie Newlin, RN, MSN, AGPCNP-BC; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Amanda Brink, DNP; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Katie Newlin, RN, MSN, AGPCNP-BC
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Katie Newlin, RN, MSN, AGPCNP-BC; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Ashley Martinez, DNP, CBCN; Sanita Burgic, MSN, APRN, AGNP-C; Katie Newlin, RN, MSN, AGPCNP-BC; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Katie Newlin, RN, MSN, AGPCNP-BC; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Danielle Roman, PharmD, BCOP
Conference Coverage
12/11/2025
Danielle Roman, PharmD
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD,...
12/11/2025
Oncology Learning Network APP Institute
Videos
10/09/2025
Tiffany A. Traina, MD
In this introduction, Dr Tiffany Traina sets the stage for the session by outlining the current standard of care for programmed cell death protein 1 positive (PD-L1+) mTNBC.
In this introduction, Dr Tiffany Traina sets the stage for the session by outlining the current standard of care for programmed cell death protein 1 positive (PD-L1+) mTNBC.
In this introduction, Dr Tiffany...
10/09/2025
Oncology Learning Network APP Institute
Research Review
04/10/2025
Janelle Bradley
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in...
04/10/2025
Oncology Learning Network APP Institute
Research Review
11/20/2024
Allison Casey
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned...
11/20/2024
Oncology Learning Network APP Institute
Research Review
04/26/2024

Allison Casey

Allison Casey
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented...
04/26/2024
Oncology Learning Network APP Institute